Som jag skrivit tidigare är dessa lows betingat av 2 saker. Först är det en tunn köpsida som inte orkar svälja säljposter av större storlek. Sen är det ? hur PHI ska finansiera verksamheten på lite längre sikt.
Det var troligen säljarens (NON) motiv att avyttra den stora volymen som skedde i fredags. Bägge de 2 sakerna hör ihop. Osäkerhet är en akties största fiende brukar jag säga. Man är snabbare att söka säljknappen än att avvakta och vänta in info som reder ut ev spörsmål man kan ha. Nåväl,jag är ganska säker på att Bolaget har full koll på detta och kommer med besked vad det lider.
Séminaire
Vendredi 14 Novembre 2025 à 11h00.
Quantitative phase imaging of the dynamics of epithelial monolayers
Dag Kristian DYSTHE
(University of Oslo)
Salle de séminaires Lippmann
Invité(e) par
Olivier Vincent
présentera en 1 heure :
''
I will briefly introduce my path from studying processes in passive inorganic to active biological materials. The bulk of the talk will concern 2D and 3D Quantitative Phase Imaging (QPI) to analyze the height, area, and volume fluctuations of cells in epithelial monolayers. I will discuss the two imaging modalities, what information is available from the commercial microscopes (Holomonitor and Tomocube) and how we achieve quantitative data of cell area, height, volume and dry mass fraction. I will discuss the new insights into cell volume regulation and epithelial monolayer dynamics that we get from the novel QPI data sets.
The FNIH Salutes Science Leading the Way
For more than a quarter century, the FNIH has contributed to significant progress in shaping the course of biomedical science and human health. We have catalyzed innovation and discovery by implementing collaborations and programs to answer the toughest scientific questions. Our initiatives have sped the development of new diagnostics, therapies, and cures. Through education, awards, and other projects, we have helped cultivate global thought leadership, propel scientific careers, and deliver high-quality patient care. At every step of the way, science has served as our beacon. LänkWhat We Do
- Engage top NIH scientists with counterparts in foundations, academic research institutions, life science companies, and patient organizations to address the most pressing health challenges
- Design large, innovative, precompetitive research partnerships, with a governance framework for oversight
- Raise private-sector money and manage relationships to ensure accountability
- Manage project timelines and finances to drive results
- Leverage private sector dollars and know-how to ensure the U.S. remains the worldwide leader in biomedical research
Early insights? Blazing-fast analysis (under 1 minute!), strong correlations on motility, and eye-opening concentration data that highlights AI's edge. Full results are intriguing—stay tuned for the complete case study reveal soon!
This could transform genetic selection and herd fertility for breeders worldwide. And you can be a pioneer by joining our case study.
Veterinary specialists, bovine repro experts, and AI enthusiasts: Want to join our next case study and validate cutting-edge tech in your field? Drop in the comments “Case Study” or Reach out via DM to collaborate!




Inga kommentarer:
Skicka en kommentar